LM 609, MEDI 523, Anti-alphavbeta3 Integrin Recombinant Antibody
Etaracizumab (LM 609) is an alphavbeta3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer.
CAS Number:
[892553-42-3]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted